Carcinoma, Non-Small-Cell Lung Concept

subject area of

• 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer  Journal Articles
• 18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review  Journal Articles
• In Vitro Survival of Nonsmall Cell Lung Cancer Cells Following Combined Treatment with Ionizing Radiation and Photofrin‐mediated Photodynamic Therapy  Journal Articles
• MCM7and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer  Journal Articles
• A Case of Successful Pembrolizumab Rechallenge in a Patient with Non-Small-Cell Lung Cancer and Grade 3 Dermatomyositis  Journal Articles
• A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer  Conferences
• A Division of Labor between YAP and TAZ in Non–Small Cell Lung Cancer  Journal Articles
• A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer  Journal Articles
• A Novel Neoadjuvant Therapy for Operable Locally Invasive Non–Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574)  Journal Articles
• A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer  Journal Articles
• A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer  Journal Articles
• A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer: A Study of the PMH Phase II Consortium  Journal Articles
• A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol.  Journal Articles
• A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non–Small-Cell Lung Cancer  Journal Articles
• A Poor Prognostic ALK Phenotype: A Review of Molecular Markers of Poor Prognosis in ALK Rearranged Nonsmall Cell Lung Cancer.  Journal Articles
• A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer  Journal Articles
• A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes  Journal Articles
• A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer  Journal Articles
• A biological staging model for operable non-small cell lung cancer  Journal Articles
• A comparison of the costs of paclitaxel and best supportive care in stage IV non-small-cell lung cancer.  Journal Articles
• A meta-analysis of Kang`ai injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer  Journal Articles
• A mixed methods approach to understand variation in lung cancer practice and the role of guidelines  Journal Articles
• A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.  Journal Articles
• A pilot study of whole body hyperthermia and local irradiation for advanced non-small cell lung cancer confined to the thorax  Journal Articles
• A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience  Journal Articles
• A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer.  Journal Articles
• A reply to “Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model”  Journal Articles
• A single institution study evaluating outcomes of PD-L1 high KRAS-mutant advanced non-small cell lung cancer (NSCLC) patients treated with first line immune checkpoint inhibitors  Journal Articles
• ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis  Journal Articles
• Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer  Journal Articles
• Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update  Journal Articles
• Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?  Journal Articles
• Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review  Journal Articles
• Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.  Journal Articles
• Adjuvant therapy for non-small cell lung cancer.  Journal Articles
• Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future  Journal Articles
• Alterations of immune response of non-small cell lung cancer with Azacytidine  Journal Articles
• Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer  Journal Articles
• Amplifying Outcomes: Checkpoint Inhibitor Combinations in First-Line Non-Small Cell Lung Cancer  Journal Articles
• An Ominous Facial Droop  Journal Articles
• An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer.  Journal Articles
• Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer.  Journal Articles
• Anemia in patients with advanced or metastatic non-small cell lung cancer.  Journal Articles
• Angiogenesis and non-small cell lung cancer  Journal Articles
• Antiangiogenic Therapies in Non-Small-Cell Lung Cancer  Journal Articles
• Artificial Intelligence Algorithm Can Predict Lymph Node Malignancy from Endobronchial Ultrasound Transbronchial Needle Aspiration Images for Non-Small Cell Lung Cancer.  Journal Articles
• Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data  Journal Articles
• Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non–small-Cell Lung Cancer  Journal Articles
• Association between Chinese Medicine Therapy and Survival Outcomes in Postoperative Patients with NSCLC: A Multicenter, Prospective, Cohort Study  Journal Articles
• Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy  Journal Articles
• BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal Brachytherapy  Journal Articles
• Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer  Journal Articles
• Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck  Journal Articles
• Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis  Journal Articles
• Brain Metastases in Non–Small-Cell Lung Cancer  Journal Articles
• Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC  Journal Articles
• Canada's Population Health Model (POHEM)  Journal Articles
• Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy  Journal Articles
• Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens  Journal Articles
• Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC  Journal Articles
• Canadian Consensus Recommendations on the Management of MET-Altered NSCLC  Journal Articles
• Canadian Consensus: A New Systemic Treatment Algorithm for Advanced EGFR-Mutated Non-Small-Cell Lung Cancer  Journal Articles
• Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer  Journal Articles
• Canadian Perspectives: Update on Inhibition of ALK-Positive Tumours in Advanced Non-Small-Cell Lung Cancer  Journal Articles
• Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non–Small-Cell Lung Cancer – Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial  Journal Articles
• Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer  Journal Articles
• Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α  Journal Articles
• Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline  Journal Articles
• Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study  Journal Articles
• Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non–Small-Cell Lung Cancer in a Publicly Funded Health Care System  Journal Articles
• Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial  Journal Articles
• Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: A systematic review and meta-analysis  Journal Articles
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.  Journal Articles
• Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?  Journal Articles
• Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.  Journal Articles
• Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review  Journal Articles
• Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts  Journal Articles
• Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients  Journal Articles
• Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.  Journal Articles
• Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer  Journal Articles
• Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer  Journal Articles
• Combination chemotherapy confers modest survival advantage in patients with advanced non-small cell lung cancer: report of a Canadian multicenter randomized trial.  Journal Articles
• Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial  Journal Articles
• Combined chemotherapy and radiation therapy for non-small-cell lung cancer.  Journal Articles
• Combined modality therapy for lung cancer.  Journal Articles
• Commentary: Seek (the nodes) and you shall find (the nodes)  Journal Articles
• Commentary: Wedge versus segmentectomy—It is best to err on the side of caution  Journal Articles
• Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non–Small Cell Lung Cancer  Journal Articles
• Complete Response and Survival Outcomes in Patients with Advanced Cancer on Immune Checkpoint Inhibitors  Journal Articles
• Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study  Journal Articles
• Computed Tomography Screening for Lung Cancer without a Smoking Cessation Program—Not a Cost-Effective Idea  Journal Articles
• Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans  Journal Articles
• Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer  Journal Articles
• Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study  Journal Articles
• Correspondence Re: Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model  Journal Articles
• Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer  Journal Articles
• Cost of combined modality interventions for stage III non-small-cell lung cancer.  Journal Articles
• Cost-Effectiveness Analysis Comparing Conventional Versus Stereotactic Body Radiotherapy for Surgically Ineligible Stage I Non–Small-Cell Lung Cancer  Journal Articles
• Cost-Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR-Mutation-Positive Non-Small Cell Lung Cancer  Journal Articles
• Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China  Journal Articles
• Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer  Journal Articles
• Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module.  Conferences
• Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer  Journal Articles
• Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC.  Journal Articles
• Cost-of-Illness Study for Non-Small-Cell Lung Cancer Using Real-World Data  Journal Articles
• Crizotinib Inhibition of ROS1-Positive Tumours in Advanced Non-Small-Cell Lung Cancer: A Canadian Perspective  Journal Articles
• Current and Future Treatment Options in the Management of Stage III NSCLC  Journal Articles
• Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer  Journal Articles
• DEALE-ing with Lung Cancer and Heart Failure  Journal Articles
• Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial  Journal Articles
• Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer  Journal Articles
• Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non–Small Cell Lung Cancer in Canada  Journal Articles
• Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model  Journal Articles
• Diagnostic and therapeutic approaches to lung cancer in Canada and their costs  Journal Articles
• Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysis  Journal Articles
• Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?  Journal Articles
• Dosimetric Impact of Online Correction via Cone-Beam CT-Based Image Guidance for Stereotactic Lung Radiotherapy  Journal Articles
• Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study  Journal Articles
• Economic Analysis of NCIC CTG JBR.10: A Randomized Trial of Adjuvant Vinorelbine Plus Cisplatin Compared With Observation in Early Stage Non–Small-Cell Lung Cancer—A Report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non-Small Cell Lung Cancer  Journal Articles
• Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)  Journal Articles
• Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes  Journal Articles
• Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer  Journal Articles
• Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs  Journal Articles
• Endobronchial Ultrasound Staging of Operable Non-small Cell Lung Cancer  Journal Articles
• Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline  Journal Articles
• Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy  Journal Articles
• Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome  Journal Articles
• Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process.  Journal Articles
• Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.  Journal Articles
• First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer  Journal Articles
• First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review  Journal Articles
• Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer  Journal Articles
• Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter  Journal Articles
• Grain‐sized moxibustion promotes NK cell antitumour immunity by inhibiting adrenergic signalling in non–small cell lung cancer  Journal Articles
• Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.  Journal Articles
• Herceptest: Her2 expression and gene amplification in non-small cell lung cancer  Journal Articles
• High Risk for Thoracotomy but not Thoracoscopic Lobectomy  Journal Articles
• How Long to Treat Acute Venous Thrombosis in Cancer: Can Treatment Be Personalized?  Journal Articles
• Hypoxia‐inducible factor‐1α in non small cell lung cancer: Relation to growth factor, protease and apoptosis pathways  Journal Articles
• Identification of Direct p73 Target Genes Combining DNA Microarray and Chromatin Immunoprecipitation Analyses  Journal Articles
• Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.  Journal Articles
• Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review  Journal Articles
• Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer  Journal Articles
• Impact of the COVID-19 pandemic on non–small-cell lung cancer pathologic stage and presentation  Journal Articles
• Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario Perspective.  Journal Articles
• Improving the Quality of Lung Cancer Care in Ontario: The Lung Cancer Disease Pathway Initiative  Journal Articles
• In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer  Journal Articles
• Interobserver Variation in the Computed Tomographic Evaluation of Mediastinal Lymph Node Size in Patients With Potentially Resectable Lung Cancer  Journal Articles
• Is Positron Emission Tomography for the Management of Potentially Operable Non‐Small Cell Lung Cancer an Efficient Use of Quebec Health Care Resources?  Journal Articles
• Is postoperative radiotherapy for radically resected NSCLC detrimental and therefore unnecessary?  Journal Articles
• Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience  Journal Articles
• Lung cancer in pulmonary fibrosis: no room for nihilism!  Journal Articles
• Lung cancer.  Journal Articles
• Lung cancer.  Journal Articles
• Lung cancer.  Journal Articles
• Lung cancer.  Journal Articles
• Lung cancer.  Journal Articles
• Lung cancer.  Journal Articles
• Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial  Journal Articles
• Management of Metastatic Non-Small-Cell Lung Cancer and a Consideration of Cost  Journal Articles
• Management of unresected stage III non-small cell lung cancer: a systematic review.  Journal Articles
• Matrix Metalloproteinase-19 Promotes Metastatic BehaviorIn Vitroand Is Associated with Increased Mortality in Non–Small Cell Lung Cancer  Journal Articles
• Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer.  Journal Articles
• Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer  Journal Articles
• Metabolic imaging in non-small-cell lung cancer radiotherapy  Journal Articles
• Metformin for chemo-radio-sensitization of NSCLC  Journal Articles
• Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer  Journal Articles
• Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK  Journal Articles
• Method to Our Madness or Madness in Our Methods? Pitfalls in Trial Methodology  Journal Articles
• MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function  Journal Articles
• Minimally invasive thoracic surgery for early stage non-small cell lung cancer  Journal Articles
• Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer  Journal Articles
• Molecular Testing in Non–Small-Cell Lung Cancer: A Call to Action  Journal Articles
• Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial  Journal Articles
• Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions  Journal Articles
• N2 is not N2 is not N2  Journal Articles
• Near-Infrared Fluorescence-Guided Segmentectomy: Added Benefit of Indocyanine Green Dye Diminishes With Surgeon Experience.  Journal Articles
• Near-infrared mapping with indocyanine green is associated with an increase in oncological margin length in minimally invasive segmentectomy  Journal Articles
• Neuroanatomical location of lung cancer brain metastases in 234 patients with a focus on cancer subtyping and biomarkers.  Journal Articles
• Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!  Journal Articles
• Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer  Journal Articles
• Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC  Journal Articles
• Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer  Journal Articles
• Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study  Journal Articles
• Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy  Journal Articles
• Objective Responses in Patients with Malignant Melanoma or Renal Cell Cancer in Early Clinical Studies Do Not Predict Regulatory Approval  Journal Articles
• Optimal first-line immune checkpoint inhibitor treatment in lung cancer: how to choose?  Journal Articles
• Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer  Journal Articles
• Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC  Journal Articles
• PET–CT imaging in non-small-cell lung cancer  Journal Articles
• Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer  Journal Articles
• Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial  Journal Articles
• Pharmacoeconomics of Systemic Therapies for Lung Cancer  Journal Articles
• Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations  Journal Articles
• Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer  Journal Articles
• Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors  Journal Articles
• Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients  Journal Articles
• Phase I Study of Acivicin and Cisplatin in Non-Small-Cell Lung Cancer  Journal Articles
• Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer  Journal Articles
• Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer.  Journal Articles
• Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non–Small-Cell Lung Cancer  Journal Articles
• Phase II Study of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy for Stage T1-3 N0 M0 Non-Small Cell Lung Cancer: NCIC CTG BR.25  Journal Articles
• Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non–Small Cell Lung Cancer  Journal Articles
• Phase II Study of Troxacitabine (BCH-4556) in Patients with Advanced Non-Small-Cell Lung Cancer  Journal Articles
• Phase II Trial of 13-cis-Retinoic Acid Plus Interferon   in Non-Small-Cell Lung Cancer: For the National Cancer Instit ute of Canada Clinical Trials Group  Journal Articles
• Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer  Journal Articles
• Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma  Journal Articles
• Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.  Journal Articles
• Photodynamic therapy in nonsmall cell lung cancer: a systematic review  Journal Articles
• Pointed Progress in Second-Line Advanced Non–Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition  Journal Articles
• Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors  Journal Articles
• Positron Emission Tomography Plus Computed Tomography for Staging Early Lung Cancer  Journal Articles
• Positron Emission Tomography in Staging Early Lung Cancer  Journal Articles
• Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial  Journal Articles
• Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review  Journal Articles
• Postoperative Chemotherapy in Nonsmall Cell Lung Cancer: A Systematic Review  Journal Articles
• Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline  Journal Articles
• Practitioner feedback on lung cancer practice guidelines in Ontario.  Journal Articles
• Predicting 2-Year Survival for Radiation Regimens in Advanced Non-small Cell Lung Cancer  Journal Articles
• Predictors of Immunotherapy-Induced Immune-Related Adverse Events  Journal Articles
• Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non–small-cell lung cancer: Which is better?  Journal Articles
• Preoperative mediastinal staging in early-stage lung cancer: Targeted nodal sampling is not inferior to systematic nodal sampling  Journal Articles
• Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence  Journal Articles
• Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer  Journal Articles
• Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value  Journal Articles
• Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers  Journal Articles
• RAVAL trial: Protocol of an international, multi-centered, blinded, randomized controlled trial comparing robotic-assisted versus video-assisted lobectomy for early-stage lung cancer  Journal Articles
• RNAi screen identifies essential regulators of human brain metastasis-initiating cells  Journal Articles
• Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non–Small-cell Lung Cancer: A Systematic Review  Journal Articles
• Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29  Journal Articles
• Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer  Conferences
• Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer  Conferences
• Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer  Journal Articles
• Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18  Journal Articles
• Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer  Journal Articles
• Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15)  Journal Articles
• Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer  Journal Articles
• Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study  Journal Articles
• Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia  Journal Articles
• Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non–Small-Cell Lung Cancer: ECOG 5597  Journal Articles
• Rapid atrophy of cardiac left ventricular mass in patients with non‐small cell carcinoma of the lung  Journal Articles
• Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth  Journal Articles
• Real-World Benefit of Nivolumab in A Canadian Non-Small-Cell Lung Cancer Cohort  Journal Articles
• Real-World Treatment Patterns and Survival in Stage IV Non-Small-Cell Lung Cancer in Canada  Journal Articles
• Resource Use in the Last Three Months of Life by Lung Cancer Patients in Southern Ontario  Journal Articles
• Respiratory Failure Following Vinorelbine Tartrate Infusion in a Patient With Non-small Cell Lung Cancer  Journal Articles
• Response to Screening for Brain Metastases in Resectable Non–Small Cell Lung Cancer  Journal Articles
• Retrospective Cohort Study of Unresectable Stage III Non-Small-Cell Lung Cancer in Canada  Journal Articles
• Robotic Lobectomy Is Cost-effective and Provides Comparable Health Utility Scores to Video-assisted Lobectomy  Journal Articles
• Robotic Versus Video-Assisted Thoracoscopic Lung Resection During Early Program Development  Journal Articles
• Robotic resection of Stage III lung cancer: an international retrospective study†  Journal Articles
• Robotic vs Thoracoscopic Anatomic Lung Resection in Obese Patients: A Propensity-Adjusted Analysis  Journal Articles
• Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer  Journal Articles
• Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21  Journal Articles
• Routine systematic sampling versus targeted sampling during endobronchial ultrasound: A randomized feasibility trial  Journal Articles
• SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer  Journal Articles
• SUNSET: Stereotactic Radiation for Ultracentral Non–Small-Cell Lung Cancer—A Safety and Efficacy Trial  Journal Articles
• Safety and Clinical Outcomes of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Diseases  Journal Articles
• Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer  Journal Articles
• Safety and efficacy of lorlatinib against ALK-driven refractory or relapsed neuroblastoma  Journal Articles
• Sclerosing angiomatoid nodular transformation of the spleen: Case report  Journal Articles
• Second-Line Treatment of Non-Small Cell Lung Cancer: New Developments for Tumours Not Harbouring Targetable Oncogenic Driver Mutations  Journal Articles
• Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline  Journal Articles
• Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219  Journal Articles
• Serum Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Prognosticating Immunotherapy Efficacy  Journal Articles
• Single Nucleotide Polymorphisms of the ERAP1 Gene and Risk of NSCLC: A Comparison of Genetically Distant Populations, Chinese and Caucasian.  Conferences
• Skeletal Muscle Depletion Is Associated with Reduced Plasma (n-3) Fatty Acids in Non-Small Cell Lung Cancer Patients  Journal Articles
• Spatial mapping of mitochondrial networks and bioenergetics in lung cancer  Journal Articles
• Stage III Non–Small-Cell Lung Cancer: Establishing a Benchmark for the Proportion of Patients Suitable for Radical Treatment  Journal Articles
• Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)  Journal Articles
• Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis  Journal Articles
• Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.  Journal Articles
• Stuck between a rock and a hard place: ILD + NSCLC = LIM  Journal Articles
• Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer  Journal Articles
• Surgeons’ assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer  Journal Articles
• Surgery after Chemoradiotherapy in Patients with Stage III (n2 or N3, Excluding T4) Non-Small-Cell Lung Cancer: A Systematic Review  Journal Articles
• Survival effects of time to surgery for Stage I lung cancer: A population-based study  Journal Articles
• Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center  Journal Articles
• Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update  Journal Articles
• Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update  Journal Articles
• Takotsubo Cardiomyopathy Secondary in Part to Cancer-Related Pain Crisis: A Case Report  Journal Articles
• Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer  Journal Articles
• Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?  Journal Articles
• Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline  Journal Articles
• Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial  Journal Articles
• Temporal trends in the incidence and relative survival of non-small cell lung cancer in Canada: A population-based study  Journal Articles
• The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study.  Journal Articles
• The Use of Systemic Treatment in the Maintenance of Patients with Non–Small Cell Lung Cancer: A Systematic Review  Journal Articles
• The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population.  Journal Articles
• The association of adiponectin gene promoter variations with non-small cell lung cancer in a Han Chinese population.  Journal Articles
• The burden of death following discharge after lobectomy  Journal Articles
• The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer  Journal Articles
• The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.  Journal Articles
• The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries.  Journal Articles
• The effect of surgeon volume on procedure selection in non–small cell lung cancer surgeries  Journal Articles
• The efficacy and toxicity of immune checkpoint inhibitors in a real-world older patient population  Journal Articles
• The impact of practice guidelines and funding policies on the use of new drugs in advanced non‐small cell lung cancer*  Journal Articles
• The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancer  Journal Articles
• The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer  Journal Articles
• The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer  Journal Articles
• The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non–small-cell lung cancer: A systematic review  Journal Articles
• The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.  Journal Articles
• Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline  Journal Articles
• Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update  Journal Articles
• Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline  Journal Articles
• Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update  Journal Articles
• Time‐resolved fluorescence and diffuse reflectance for lung squamous carcinoma margin detection  Journal Articles
• Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.  Journal Articles
• Towards a biological staging model for operable non-small cell lung cancer  Journal Articles
• Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: A secondary analysis of the LUSTRE randomized trial.  Journal Articles
• Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers  Journal Articles
• Translation of Knowledge to Practice—Improving Awareness in NSCLC Molecular Testing  Journal Articles
• Treatment of non-small-cell lung cancer by high-dose-rate intraluminal brachytherapy.  Journal Articles
• Treatment patterns and outcomes in KRAS‐positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study  Journal Articles
• Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24  Journal Articles
• Trends in Survival Based on Treatment Modality in Non-Small Cell Lung Cancer Patients: A Population-Based Study  Journal Articles
• Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer  Journal Articles
• Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables  Journal Articles
• Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada  Journal Articles
• Tyrosine Kinase Inhibitor Therapy in Unresectable Locally Advanced NSCLC: Keep Holding Our Breaths or Time to Take a Breather?  Journal Articles
• Unerwünschte (kardio-)vaskuläre Wirkungen von Vinorelbin beim nichtkleinzelligen Bronchialkarzinom1  Journal Articles
• Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Journal Articles
• Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum.  Journal Articles
• Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease  Journal Articles
• Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial  Journal Articles
• Uptake and survival effects of minimally invasive surgery for lung cancer: A population-based study  Journal Articles
• Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Journal Articles
• Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a systematic review.  Journal Articles
• Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.  Journal Articles
• Vascular Endothelial Growth Factor Concentration as a Predictive Marker: Ready for Primetime?  Journal Articles
• Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer  Journal Articles
• Wait times in the management of non–small cell lung carcinoma before, during and after regionalization of lung cancer care: a high-resolution analysis  Journal Articles
• Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.  Journal Articles
• YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer  Journal Articles
• [A multicenter, large-sample, randomized clinical trial on improving the median survival time of advanced non-small cell lung cancer by combination of Ginseng Rg3 and chemotherapy].  Journal Articles
• ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results  Journal Articles
• p21WAF1 protein expression determined by quantitative immunoassay in relation to non-small-cell lung cancer aggressiveness  Journal Articles
• “Incomplete Resection” in Non–Small Cell Lung Cancer: Need for a New Definition  Journal Articles